Skip to main content
Equibles
CADL logo

CADL · Candel Therapeutics, Inc.

Track CADL — free

Use CADL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$12.78 -0.19 (-1.46%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$1.01B
Shares
76.52M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type Filing Date Period Open
10-Q 2026-08-13 2026-06-30
8-K 2026-08-13 —
Investor Event Transcript 2026-08-12 2026-09-30
8-K 2026-06-24 2026-06-23
8-K 2026-06-16 2026-06-12
Investor Event Transcript 2026-06-03 2026-06-30
Investor Event Transcript 2026-05-15 2026-06-30
8-K 2026-05-15 —
8-K 2026-05-14 —
10-Q 2026-05-14 2026-03-31
DEF 14A 2026-04-29 2026-06-23
10-K 2026-03-12 2025-12-31
8-K 2026-03-12 —
8-K 2026-02-23 2026-02-19
8-K 2026-02-19 —
8-K 2025-12-05 —
8-K 2025-11-13 —
10-Q 2025-11-13 2025-09-30
8-K 2025-10-14 —
8-K 2025-08-21 2025-08-18
8-K 2025-08-14 —
10-Q 2025-08-14 2025-06-30
8-K 2025-06-24 2025-06-23
8-K 2025-06-23 2025-06-20
8-K 2025-06-18 2025-06-17
8-K 2025-06-06 2025-06-04
8-K 2025-05-28 —
8-K 2025-05-22 —
10-Q 2025-05-13 2025-03-31
8-K 2025-05-13 —
DEF 14A 2025-04-29 2025-06-17
8-K 2025-04-23 —
8-K 2025-03-27 2025-03-26
8-K 2025-03-13 —
10-K 2025-03-13 2024-12-31
8-K 2025-02-25 —
8-K 2025-01-13 —
8-K 2024-12-13 2024-12-12
8-K 2024-12-11 —
10-Q 2024-11-14 2024-09-30
8-K 2024-11-14 —
8-K 2024-10-28 —
8-K 2024-08-13 —
10-Q 2024-08-13 2024-06-30
8-K 2024-06-28 2024-06-26
8-K 2024-05-30 2024-05-29
DEF 14A 2024-05-30 2024-06-26
8-K 2024-05-23 —
8-K 2024-05-14 —
10-Q 2024-05-14 2024-03-31
Showing 1–50 of 114 filings
Key facts CIK 1841387 CUSIP 137404109 13F (30d) 109 filings 109 filers Visit website Investor relations